The objectives were to determine (i) whether the expression levels of the MOTS-c gene and protein vary among different types of adrenal tumors, and (ii) whether the localization of the MOTS-c protein is altered not only among the various adrenal tumors but also during the progression of ACC. Here, MT-RNR1 is linked to adrenal cortex carcinoma.